How does Dysport work?
Dysport is comprised of a naturally occurring, purified protein. Dysport safely and temporarily blocks muscle activity. By temporarily stopping a muscle from contracting, it no longer is creating dynamic lines and wrinkles.
A common question we get is “what’s the difference between Botox and Dysport”? To put it simply, Dysport has a faster onset and larger field of action. On the other hand, Botox is more localized to the injection site. A consultation will determine which neuromodulator is best for your personal anatomy and goals.
Expert knowledge of facial anatomy is the key to outstanding results. Precise dose and placement determine the success of the treatment. Dr. Cox has performed multiple clinical trials for Dysport right here in Chapel Hill and travels frequently teaching other physicians on best injection practices and how to avoid complications.
Is Dysport safe?
The FDA has approved Dysport to safely treat wrinkles. Like any surgical or non-surgical procedure, there are risks. As an international teacher and trainer of other physicians in facial anatomy and injection technique, Dr. Cox stresses the importance of finding an experienced physician who understands the finer points of injectable treatment. Dr. Cox performed clinical trials for Dysport as well as new neuromodulators not yet on the market and is internationally recognized for her skills as an injector.
Dysport treatments are well tolerated. The treatment is comprised of a series of precise injections with a very small needle. This process only takes a few minutes. Patients often compare the feeling to having their eyebrows plucked.
There is no downtime associated with Dysport. Once the injections are complete, there is typically mild swelling and redness around the pin-prick injection sites. This dissipates within a few minutes.
You will begin to see results from Dysport within three to four days. Full results will appear two weeks after treatment. Dysport typically last three to four months. One Dysport treatment will reduce or eliminate dynamic wrinkles in the treatment area. Wrinkles that are etched in (remain visible at rest) will need multiple sessions for optimal results. In the case of etched lines, additional treatment modalities may be needed.
Related Clinical Trials
Dr. Cox was principal investigator in the study “A Phase III, Open-Label, Multicenter Study to Assess the Long-Term Safety of Repeat Administrations of 52120 in the Treatment of Glabellar Lines.” This product, originally called Reloxin, is now marketed as Dysport. The study was performed September 2004 to December 2005.
Dr. Cox was principal investigator for the study ”A Phase III, Open-Label, Multicenter Study to Assess the Long-Term Safety of Repeat Administrations of Reloxin® in the Treatment of Glabellar Lines.” This neuromodulator is now marketed as Dysport. The study was active December 2005 through March 2012.
Dr. Cox was principal investigator for the study “A Phase III, Randomized, Placebo-Controlled, Multi-Center, Double-Blind Study of the Safety and Duration of Efficacy of Reloxin® (Botulinum Type A Toxin) in Correction of Moderate to Severe Glabellar Lines.” This product is now known as Dysport. The study was performed June 2006 through June 2007.
Dr. Cox completed work for this study “A Multicenter, Randomized, Dose-Ranging, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines” serving as the principal investigator. This study began in November of 2018 and ended in September of 2020.